Khorana and colleagues found that pancreatic cancer patients with high TF expression in tumors had a high rate of symptomatic VTE (26.3%) compared to a low rate (4.5%) in pancreatic cancer patients with low TF expression in their tumors [17]. This evidence concerns the gene TF and familial pancreatic carcinoma.